Pulmatrix
PULM
5 hedge funds and large institutions have $50M invested in Pulmatrix in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
131,439% more capital invested
Capital invested by funds: $38K → $50M (+$49.9M)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
67% more funds holding
Funds holding: 3 → 5 (+2)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
+$34.9M |
| 2 |
PVMCI
Polaris Venture Management Co IV
Boston,
Massachusetts
|
+$15.4M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$46.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$31K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.94K |
PULM Hedge Fund Activity: Q2 2015 in Review
5 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Pulmatrix (PULM) for Q2 2015, worth a combined $50M — up 131,439% from $38K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PULM positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Polaris Venture Management Co V, opening a new position worth an estimated $34.9M. The largest seller was Morgan Stanley, exiting entirely with an estimated $31K sold.
- 5 institutional investors held Pulmatrix (PULM) as of Q2 2015, up from 3 in Q1 2015.
- Funds reported $50M of Pulmatrix stock for Q2 2015, up 131,439% quarter-over-quarter.
- 3 funds opened new Pulmatrix positions in Q2 2015 and 1 closed out, a net change of +2 holders.
- The largest Pulmatrix buyer in Q2 2015 was Polaris Venture Management Co V, an estimated $34.9M added.
- The largest Pulmatrix seller in Q2 2015 was Morgan Stanley, an estimated $31K sold.
Based on aggregated 13F filings for Q2 2015.